Clinical Trials Browser

Fluorodeoxyglucose F18 × Tumor-Agnostic × 30 days × Clear all

NCT02130492 2026-05-15

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

Phase 1/2 Suspended

Neoplasms